Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

HISTOPLASMA CAPSULATUM - ANVISA Registration 81504790103

Access comprehensive regulatory information for HISTOPLASMA CAPSULATUM in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81504790103 and manufactured by IMMY INC. The registration is held by PASSROD IMPORTAÇÃO E EXPORTAÇÃO DE PRODUTOS PARA SAÚDE LTDA - ME with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 2 companies making the same product including DIASORIN MOLECULAR LLC, MIRAVISTA DIAGNOSTICS, LLC, and 2 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
2 Competitors
2 Recent Registrations
81504790103
Registration Details
ANVISA Registration Number: 81504790103
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

Clarus Histoplasma Galactomannan EIA
Risk Class II

Registration Details

81504790103

25351625780201964

26185222000110

Company Information

IMMY INC
United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Jan 27, 2020

VIGENTE

09/18/2025 19:00:01

Companies Making Similar Products
Top companies providing products with the same technical name: "HISTOPLASMA CAPSULATUM"